Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Bactrim	O
DS	O
/	O
adhesive	O
tape	O
/	O
Latex	O
/	O
Prevacid	O
/	O
lisinopril	O
/	O
alendronate	O
sodium	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Hyponatremia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___,	O
___	O
speaking	O
only,	O
with	O
h/o	O
HTN,	O
osteoporosis,	O
GERD,	O
HTN,	O
retained	O
gallstones	O
s/p	O
CCY	O
p/w	O
hyponatremia.	O
She	O
was	O
seen	O
by	O
her	O
PCP	O
yesterday	O
for	O
___	O
infusion	O
and	O
lytes	O
were	O
checked	O
-	O
Na	O
was	O
found	O
to	O
be	O
124	O
and	O
she	O
was	O
referred	O
to	O
the	O
ER.	O
Her	O
PCP	O
___	O
documents	O
the	O
recent	O
changes	O
in	O
her	O
medications:	O
___	O
lisinopril	O
d/ced	O
due	O
to	O
angioedema,	O
losartan	O
started.	O
___	O
f/u	O
labs	O
show	O
K	O
2.9-->	O
brief	O
ER	O
stay	O
for	O
repletion,	O
spironolactone	O
added	O
to	O
regimen	O
and	O
losartan	O
stoppped.	O
___	O
losartan	O
restarted.	O
___	O
infusion.	O
___	O
f/u,	O
doing	O
well,	O
last	O
dose	O
spironolactone	O
on	O
___.	O
In	O
the	O
ER,	O
initial	O
VS	O
98.6	O
60	O
119/49	O
20	O
98%	O
on	O
RA.	O
Labs	O
showed	O
repeat	O
Na	O
of	O
120,	O
Cr	O
1.0	O
(bl	O
0.8)	O
and	O
BUN	O
26.	O
WBC	O
was	O
normal.	O
No	O
IVF	O
were	O
given.	O
The	O
patient	O
had	O
an	O
episode	O
of	O
vomiting	O
in	O
the	O
ER	O
and	O
was	O
given	O
4	O
mg	O
IV	O
Zofran.	O
Currently,	O
the	O
patient	O
appears	O
fatigued	O
but	O
is	O
conversant	O
with	O
over	O
the	O
phone	O
___	O
interpreter.	O
She	O
states	O
that	O
her	O
PO	O
intake	O
has	O
been	O
poor	O
for	O
a	O
year	O
because	O
of	O
esophageal	O
problems	O
and	O
GI	O
upset	O
but	O
that	O
it	O
hasn't	O
been	O
especially	O
different	O
the	O
past	O
few	O
weeks.	O
She	O
rarely	O
drinks	O
fluid	O
during	O
the	O
day,	O
which	O
is	O
also	O
chronic,	O
but	O
reports	O
drinking	O
___	O
glasses	O
of	O
water	O
before	O
and	O
after	O
the	O
___	O
infusion	O
yesterday	O
per	O
instructions,	O
which	O
is	O
significantly	O
more	O
than	O
she	O
usually	O
drinks.	O
She	O
does	O
describe	O
fatigue	O
and	O
nausea/vomiting	O
x	O
1	O
in	O
the	O
ER.	O
No	O
headaches	O
or	O
vision	B-Visual_impairment
changes.	B-Visual_impairment
No	O
confusion.	B-Delirium
She	O
denies	O
positional	O
dizziness,	O
endorses	O
dry	O
mouth.	O
She	O
reports	O
she	O
has	O
been	O
taking	O
HCTZ	O
for	O
months	O
at	O
the	O
same	O
dose	O
-	O
no	O
recent	O
stoppage/start.	O
Review	O
of	O
sytems:	O
(+)	O
Per	O
HPI,	O
constipation	B-Constipation
(-)	O
Denies	O
fever,	O
chills,	O
night	O
sweats,	O
recent	O
weight	B-Weight_loss
loss	B-Weight_loss
or	O
gain.	O
Denies	O
headache,	O
sinus	O
tenderness,	O
rhinorrhea	O
or	O
congestion.	O
Denies	O
cough,	O
shortness	O
of	O
breath.	O
Denies	O
chest	O
pain	O
or	O
tightness,	O
palpitations.	O
Denies	O
diarrhea,	O
or	O
abdominal	O
pain.	O
No	O
recent	O
change	O
in	O
bowel	O
or	O
bladder	O
habits.	O
No	O
dysuria.	O
Denies	O
arthralgias	O
or	O
myalgias.	O
Ten	O
point	O
review	O
of	O
systems	O
is	O
otherwise	O
negative.	O
Past	O
Medical	O
History:	O
Papillary	O
stenosis,	O
retained	O
gallstones,	O
h/o	O
CCY	O
HTN	O
Osteoporosis	O
Anxiety	O
GERD	O
Gastroparesis	O
Social	O
History:	O
___	O
Family	O
History:	O
Non	O
contributory	O
Physical	O
Exam:	O
ADMISSION	O
EXAM:	O
=================	O
Vitals:	O
100.0	O
156/68	O
88	O
20	O
98%	O
on	O
RA	O
General:	O
Alert,	O
oriented,	B-Delirium
no	O
acute	O
distress,	O
looks	O
tired	O
HEENT:	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear	O
Neck:	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
Lungs:	O
Clear	O
to	O
auscultation	O
bilaterally,	O
no	O
wheezes,	O
rales,	O
ronchi	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
___	O
systolic	O
murmur	O
at	O
LUSB,	O
rubs,	O
gallops	O
Abdomen:	O
soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
Ext:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
Neuro:	O
CN	O
II-XII	O
intact,	O
Full	O
strength	O
in	O
___	O
bil.	O
DISCHARGE	O
EXAM:	O
===================	O
Tc98.3	O
92/57-156/68	O
87	O
20	O
100%	O
on	O
RA	O
General:	O
Alert,	O
oriented,	B-Delirium
no	O
acute	O
distress	O
HEENT:	O
Sclera	O
anicteric,	O
dry	O
MM,	O
oropharynx	O
clear	O
Neck:	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
Lungs:	O
CTAB,	O
no	O
wheezes,	O
rales,	O
ronchi	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
___	O
systolic	O
murmur	O
at	O
LUSB,	O
rubs,	O
gallops	O
Abdomen:	O
soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
Ext:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
Neuro:	O
CN	O
II-XII	O
intact,	O
Full	O
strength	O
in	O
___	O
bil.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
=================	O
___	O
09:10PM	O
BLOOD	O
WBC-8.3#	O
RBC-4.30	O
Hgb-13.5	O
Hct-35.7*	O
MCV-83	O
MCH-31.3	O
MCHC-37.7*	O
RDW-12.9	O
Plt	O
___	O
___	O
01:10PM	O
BLOOD	O
UreaN-22*	O
Creat-1.0	O
Na-124*	O
K-4.7	O
Cl-85*	O
HCO3-26	O
AnGap-18	O
___	O
09:10PM	O
BLOOD	O
Calcium-9.2	O
Phos-3.8	O
Mg-1.6	O
OTHER	O
PERTINENT	O
LABS:	O
========================	O
___	O
07:30AM	O
BLOOD	O
Cortsol-35.0*	O
___	O
09:10PM	O
BLOOD	O
TSH-1.6	O
___	O
09:10PM	O
BLOOD	O
Osmolal-254*	O
___	O
11:10PM	O
URINE	O
Osmolal-632	O
___	O
04:00PM	O
URINE	O
Osmolal-324	O
___	O
11:10PM	O
URINE	O
Hours-RANDOM	O
UreaN-1014	O
Creat-94	O
Na-51	O
K-85	O
Cl-52	O
___	O
04:00PM	O
URINE	O
Hours-RANDOM	O
UreaN-529	O
Creat-65	O
Na-18	O
K-32	O
Cl-<10	O
MICRO:	O
=============	O
BLOOD	O
CULTURES:	O
NGTD	O
PENDING	O
AT	O
TIME	O
OF	O
DISCHARGE	O
DISCHARGE	O
LABS:	O
===================	O
___	O
07:50AM	O
BLOOD	O
WBC-4.26	O
RBC-4.18*	O
Hgb-12.8	O
Hct-35.1*	O
MCV-84	O
MCH-30.7	O
MCHC-36.5*	O
RDW-12.7	O
Plt	O
___	O
___	O
12:45PM	O
BLOOD	O
Na-128*	O
K-4.2	O
Cl-95*	O
Brief	O
Hospital	O
Course:	O
___,	O
___	O
speaking	O
only,	O
with	O
h/o	O
HTN,	O
osteoporosis,	O
GERD,	O
HTN,	O
retained	O
gallstones	O
s/p	O
CCY	O
p/w	O
hyponatremia	O
secondary	O
to	O
hypovolemic	O
hyponatremia.	O
ACTIVE	O
ISSUES:	O
===================	O
#	O
HYPONATREMIA:	O
Patient	O
presented	O
to	O
her	O
PCP	O
and	O
found	O
to	O
have	O
hyponatremia	O
in	O
the	O
setting	O
of	O
increased	O
free	O
water	O
intake	O
around	O
a	O
___	O
injection.	O
There	O
was	O
no	O
evidence	O
for	O
pseudohyponatremia.	O
The	O
patient	O
was	O
symptomatic	O
manifested	O
as	O
nausea,	O
but	O
no	O
neurologic	O
deficits.	O
Initially,	O
it	O
was	O
difficult	O
to	O
distinguish	O
between	O
SIADH	O
vs.	O
hypovolemic	O
hyponatremia	O
given	O
that	O
she	O
was	O
on	O
diuretics	O
at	O
the	O
time	O
of	O
presentation.	O
Renal	O
was	O
consulted.	O
A	O
diagnosis	O
of	O
SIADH	O
was	O
her	O
serum	O
Osm	O
<	O
urine	O
osm	O
and	O
she	O
appeared	O
to	O
be	O
euvolemic	O
on	O
exam	O
as	O
well	O
as	O
her	O
urine	O
Na	O
of	O
51.	O
TSH	O
and	O
am	O
cortisol	O
were	O
normal	O
and	O
there	O
were	O
no	O
new	O
medications	O
started	O
that	O
are	O
associated	O
with	O
SIADH.	O
She	O
was	O
fluid	O
restricted	O
and	O
her	O
Na	O
remained	O
stable	O
at	O
120.	O
If	O
hypovolemic	O
hypnonatremia	O
would	O
have	O
expected	O
her	O
Una	O
to	O
be	O
<20.	O
A	O
FeUrea	O
of	O
41%	O
argues	O
against	O
hypovolemic	O
cause,	O
but	O
a	O
FeNa	O
of	O
0.45%	O
does	O
support	O
hypovolemic	O
cause.	O
She	O
was	O
then	O
given	O
a	O
1L	O
NS	O
challenge	O
and	O
her	O
free	O
water	O
restriction	O
was	O
discontinued	O
and	O
her	O
sodium	O
improved	O
to	O
a	O
discharge	O
sodium	O
of	O
128.	O
Her	O
diuretics	O
were	O
held	O
and	O
she	O
was	O
discharged	O
on	O
diltiazem	O
and	O
losartan	O
for	O
blood	O
pressure	O
control.	O
#	O
Low	O
grade	O
temp:	O
She	O
presented	O
with	O
a	O
temp	O
of	O
100.0F.	O
UA	O
was	O
unremarkable	O
and	O
Blood	O
cultures	O
were	O
pending	O
at	O
the	O
time	O
of	O
discharge.	O
CHRONIC	O
ISSUES:	O
==================	O
#	O
HTN:	O
She	O
was	O
continued	O
on	O
her	O
home	O
does	O
of	O
losartan	O
and	O
diltiazem.	O
Her	O
blood	O
pressures	O
were	O
well	O
controlled	O
during	O
the	O
hospitalization	O
with	O
systolics	O
mostly	O
in	O
the	O
110s.	O
Her	O
HCTZ/spironolactone	O
were	O
held	O
at	O
the	O
time	O
of	O
discharge.	O
.	O
#	O
GERD:	O
She	O
was	O
continued	O
on	O
a	O
pantoprazole	O
(as	O
esomeprazole	O
was	O
nonformulary),	O
and	O
reglan.	O
#	O
Anxiety:	O
She	O
was	O
continued	O
on	O
xanaxx	O
TRANSITIONAL	O
ISSUES:	O
=======================	O
#	O
CODE:FULL	O
#	O
CONTACT:	O
husband	O
___	O
___	O
#	O
MEDICATION	O
CHANGES:	O
--STOP	O
spironolactone	O
--STOP	O
Hydrochlorothiazide	O
#	O
OUTPATIENT	O
LAB	O
WORK:	O
CHEM	O
7	O
to	O
be	O
drawn	O
on	O
___	O
#	O
Continue	O
to	O
encourage	O
adequate	O
po	O
intake	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Calcium	O
500	O
+	O
D	O
*NF*	O
(calcium	O
carbonate-vitamin	O
D3)	O
500	O
mg(1,250mg)	O
-200	O
unit	O
Oral	O
TID	O
2.	O
ALPRAZolam	O
0.5	O
mg	O
PO	O
QHS	O
3.	O
Diltiazem	O
Extended-Release	O
360	O
mg	O
PO	O
DAILY	O
Hold	O
for	O
SBP	O
<	O
100	O
4.	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
5.	O
Hydrochlorothiazide	O
25	O
mg	O
PO	O
DAILY	O
6.	O
NexIUM	O
*NF*	O
(esomeprazole	O
magnesium)	O
40	O
mg	O
Oral	O
qday	O
7.	O
Metoclopramide	O
5	O
mg	O
PO	O
TID	O
8.	O
Spironolactone	O
25	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
ALPRAZolam	O
0.5	O
mg	O
PO	O
QHS	O
2.	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
3.	O
Metoclopramide	O
5	O
mg	O
PO	O
TID	O
4.	O
Calcium	O
500	O
+	O
D	O
*NF*	O
(calcium	O
carbonate-vitamin	O
D3)	O
500	O
mg(1,250mg)	O
-200	O
unit	O
Oral	O
TID	O
5.	O
Diltiazem	O
Extended-Release	O
360	O
mg	O
PO	O
DAILY	O
6.	O
NexIUM	O
*NF*	O
(esomeprazole	O
magnesium)	O
40	O
mg	O
ORAL	O
QDAY	O
7.	O
Outpatient	O
Lab	O
Work	O
Chem	O
___	O
Faxed	O
to	O
Dr.	O
___	O
at	O
___	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
PRIMARY:Hyponatremia	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
___,	O
___	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
here	O
at	O
___	O
___	O
___.	O
You	O
came	O
to	O
the	O
hospital	O
because	O
you	O
had	O
low	O
sodium.	O
We	O
had	O
the	O
kidney	O
doctors	O
also	O
___	O
during	O
this	O
admission	O
and	O
we	O
think	O
this	O
was	O
because	O
you	O
were	O
very	O
dehydrated.	O
We	O
gave	O
you	O
fluids	O
and	O
your	O
sodium	O
improved.	O
It	O
is	O
important	O
for	O
you	O
to	O
stay	O
hydrated	O
when	O
you	O
leave	O
the	O
hospital	O
and	O
continue	O
to	O
drink	O
water	O
when	O
you	O
are	O
feeling	O
thirsty.	O
On	O
___,	O
go	O
get	O
your	O
labs	O
drawn	O
The	O
following	O
changes	O
were	O
made	O
to	O
your	O
medications:	O
--STOP	O
spironolactone	O
--STOP	O
Hydrochlorothiazide	O
--CONTINUE	O
taking	O
diltiazem	O
and	O
losartan	O
Followup	O
Instructions:	O
___	O

